1982
DOI: 10.1079/bjn19820129
|View full text |Cite
|
Sign up to set email alerts
|

Effect of feeding β-sitosterol alone or in combination with cholestyramine during early life on subsequent response to cholesterol challenge in adult life in guinea-pigs

Abstract: I. Most subjects who have their large intestine removed and an ileostomy formed lead a healthy life after operation, although they are prone to a variety ofmetabolic problems. In order to determine the factors likely to lead to these metabolic disturbances a detailed assessment of ileostomy output and composition and of dietary intake in relation to nutritional and metabolic status has been made in a group of ileostomy patients living at home. 2.Thirty-six volunteers with established ileostomies (twenty-six ul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1984
1984
2014
2014

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 16 publications
0
3
0
Order By: Relevance
“…In a follow-up study conducted by the same laboratory (33), pretreated guinea pigs presented increased CYP7 activity and higher secretion of chenodeoxycholic acid, the major bile acid in the guinea pig. These findings suggest that enhancement of bile acid synthesis and excretion in neonatal life persists long after cholestyramine treatment is discontinued (33).…”
Section: Bile Acid Sequestrantsmentioning
confidence: 98%
See 1 more Smart Citation
“…In a follow-up study conducted by the same laboratory (33), pretreated guinea pigs presented increased CYP7 activity and higher secretion of chenodeoxycholic acid, the major bile acid in the guinea pig. These findings suggest that enhancement of bile acid synthesis and excretion in neonatal life persists long after cholestyramine treatment is discontinued (33).…”
Section: Bile Acid Sequestrantsmentioning
confidence: 98%
“…The US National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III emphasizes that patients with CHD, or who have a risk of CHD and LDL cholesterol (LDL-C) levels >130 mg/dL, should receive drug therapy with a goal of reducing LDL-C to <100 mg/dL (23). To date, guinea pigs have been used to analyze the effects of numerous drug treatments, including 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (6,7,(15)(16)(17)48,51,53,54,77), Acyl-CoA:Cholesterol Acyltransferase (ACAT) inhibitors (40,46), cholestyramine (27,33,80,87), fibric acids (47,82), probucol (35), and apical sodium co-dependent bile acid transporter (ASBT) inhibitors (83,84). The growing incidence of dyslipidemia in Western societies reinforces the need for an appropriate animal model for the evaluation of cholesterol lowering drugs.…”
Section: Introductionmentioning
confidence: 99%
“…on the individual early in life may alter the later development of that individual (1)(2)(3)(4)(5). Thus any adaptive response in adult life may be conditioned by the first adaptation to an external stimulus early in life (see Table 1).…”
mentioning
confidence: 99%